Belief Biomed 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BBM-H901 / Belief Biomed
NCT05203679: Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

Active, not recruiting
3
32
RoW
Single dose intravenous injection of BBM-H901
Shanghai Belief-Delivery BioMed Co., Ltd
Hemophilia B
04/24
06/28
ChiCTR2300077460: A Study to Evaluate the Safety, Tolerability and Efficacy of an Adeno-Associated Virus Vector Containing an Expression Cassette of the Human Factor IX

Recruiting
1
9
 
A single-dose intravenous infusion of BBM-H901 injection
Tongji Medical College of Huazhong University of Science&Technology; Tongji Hospital, Tongji Medical College of Huazhong University of Science&Technology, Shanghai Belief-Delivery BioMed Co., Ltd
Hemophilia B
 
 
NCT05709288: Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old

Recruiting
1
9
RoW
BBM-H901
Institute of Hematology & Blood Diseases Hospital, China
Hemophilia B
06/35
11/35
NCT04135300: Gene Therapy for Chinese Hemophilia B

Active, not recruiting
N/A
10
RoW
Single dose intravenous injection of BBM-H901
Institute of Hematology & Blood Diseases Hospital, China, East China University of Science and Technology
Hemophilia B
12/39
12/39

Download Options